Add Up The Pieces: XBI Could Be Worth $133 Thursday, December 28, 7:11 AM ET, by Market News Video Staff Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...
SPDR S&P Biotech ETF Experiences Big Outflow Tuesday, January 2, 12:23 PM ET, by Market News Video Staff Symbols mentioned in this story: XBI, KRTX, ACAD, CYTK Exchange traded funds (ETFs) trade just ...
Sum Up The Parts: XBI Could Be Worth $133 Monday, January 8, 9:11 AM ET, by Market News Video Staff Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...
XBI, KRTX, ACAD, MRNA: ETF Outflow Alert Wednesday, January 10, 10:48 AM ET, by Market News Video Staff Symbols mentioned in this story: XBI, KRTX, ACAD, MRNA Exchange traded funds (ETFs) trade just ...
Implied XBI Analyst Target Price: $134 Tuesday, January 16, 6:40 AM ET, by Market News Video Staff Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...
Interesting XBI Call Options For March 11th
By Market News Video Staff, Thursday, January 27, 1:28 PM ET
Investors in SPDR Series Trust - S&P Biotech ETF (NYSE:XBI) saw new options become available today, for the March 11th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the XBI options chain for the new March 11th contracts and identified the following call contract of particular interest.
The call contract at the $89.00 strike price has a current bid of $4.70. If an investor was to purchase shares of XBI stock at the current price level of $87.25/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock at $89.00. Considering the call seller will also collect the premium, that would drive a total return (excluding dividends, if any) of 7.39% if the stock gets called away at the March 11th expiration (before broker commissions). Of course, a lot of upside could potentially be left on the table if XBI shares really soar, which is why looking at the trailing twelve month trading history for SPDR Series Trust - S&P Biotech ETF, as well as studying the business fundamentals becomes important. Below is a chart showing XBI's trailing twelve month trading history, with the $89.00 strike highlighted in red:
Considering the fact that the $89.00 strike represents an approximate 2% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted). Should the covered call contract expire worthless, the premium would represent a 5.39% boost of extra return to the investor, or 45.73% annualized, which we refer to as the YieldBoost.
Meanwhile, we calculate the actual trailing twelve month volatility (considering the last 253 trading day closing values as well as today's price of $87.25) to be 33%. For more put and call options contract ideas worth looking at, visit StockOptionsChannel.com.
This Article's Word Cloud:ArialBelowBiotechCallsChannelConsideringInvestorsMarchOptionsSPDRSeriesStockTrustYieldBoostalsocallchartcontractcoveredcurrentexpirationexpirefillColorgreekshistoryinvestorleftlookingmonthoddsoptionspremiumpricereturnsellsharesstockstrikethattheythosetodaytradingtrailingtwelvewellwhichwillworthlesswould
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?
⤹
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.